SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-12-024373
Filing Date
2012-04-09
Accepted
2012-04-09 16:15:34
Documents
6
Period of Report
2012-05-30
Effectiveness Date
2012-04-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A a12-1817_1def14a.htm DEF 14A 1658823
3 GRAPHIC g18171bki001.jpg GRAPHIC 3880
4 GRAPHIC g18172bei001.gif GRAPHIC 111917
5 GRAPHIC g18172bei002.gif GRAPHIC 76451
6 GRAPHIC g18171ba01i001.jpg GRAPHIC 4267
7 GRAPHIC g18171ba03i001.jpg GRAPHIC 4266
  Complete submission text file 0001104659-12-024373.txt   1937337
Mailing Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31812 | Film No.: 12749843
SIC: 2836 Biological Products, (No Diagnostic Substances)